CTNM logo

CTNM

Contineum Therapeutics Inc.

$11.27
-$1.23(-9.84%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$333.00M
Volume
156.04K
52W Range
$3.35 - $20.24
Target Price
$22.80
Order:

Income Statement

MetricTrendChart
2024
Dec
OPERATING EXPENSES
Operating Expenses
$50.9M
Research & Development
$38.4M
Research Expense
$38.4M
Selling, General & Administrative
$12.5M
General & Administrative Expenses
$12.5M
Salaries & Wages
$200.0K
Depreciation & Amortization
$258.0K
Depreciation & Amortization
$258.0K
Other Operating Expenses
$-525.0K
OPERATING INCOME
Operating income
$-50.9M
EBITDA
$-41.1M
NON-OPERATING ITEMS
Intinc
$8.9M
Net Non-Operating Interest Income/Expense
$8.9M
Other Income/Expense
$269.0K
Other Special Charges
$-269.0K
PRE-TAX INCOME
EBIT
$-42.3M
Pre-Tax Income
$-42.3M
NET INCOME
Net Income
$-42.3M
Net Income (Continuing Operations)
$-42.3M
Net Income (Discontinued Operations)
$-42.3M
Net Income (Common Stockholders)
$-42.3M
Normalized Income
$-41.8M
TOTALS
Total Expenses
$50.9M
SHARE & EPS DATA
Average Shares Outstanding
$19.4M
Average Shares Outstanding (Diluted)
$19.4M
Shares Outstanding
$25.9M
Basic EPS
$-2.18
Basic EPS (Continuing Operations)
$-2.18
Diluted EPS
$-2.18
Diluted EPS (Continuing Operations)
$-2.18
OTHER METRICS
Accrued Preferred Stock Dividends
$42.3M
Other Gand A
$12.5M
Otherunder Preferred Stock Dividend
$42.3M
Preferred Stock Dividends
$42.3M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2CTNM$11.27-9.8%156.04K
3
4
5
6

Get Contineum Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.